1. Healthcare, Regulatory and Reimbursement Landscape - Turkey
Report Details:
Published:November 2012
No. of Pages: 169
Price: Single User License – US$1995
Healthcare, Regulatory and Reimbursement Landscape - Turkey
Summary
GlobalData, the industry analysis specialist, has released its latest report, “Healthcare, Regulatory
and Reimbursement Landscape - Turkey”. It is an essential source of information and analysis on
Turkey’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the
healthcare market and provides insights into the demographic, regulatory and reimbursement
landscape and healthcare infrastructure. Most importantly, the report provides valuable insights
into the trends and segmentation of the pharmaceutical and medical device markets. It is built
using data and information sourced from proprietary databases, secondary research and in-house
analysis by GlobalData’s team of industry experts.
The population of Turkey has increased significantly over the years. In 2011, Turkey had a
population of approximately 74 million. The overall population increased between 2006 and 2011
from 69.4 to 74.0 million, mainly due to the increasing life expectancy. In 2011, Turkey was the
17th most populated nation in the world. As is the case in most developed countries, the elderly
population is increasing and in 2012 comprises more than 10% of the population. The working age
group contributes more than 50% of the total population and is expected to reach 56.3% of the
total population by 2020, resulting in an increase in the available labor pool in the country.
In 2010, the pharmaceutical market of Turkey was approximately $9.8 billion and Turkey was the
sixth largest pharmaceutical market in Europe. The pharmaceutical market is to grow at a
Compound Annual Growth Rate (CAGR) of 6.1% from 2005 to 2020, and is estimated to reach
$21.6 billion in 2020.
The market for medical devices in Turkey is large due to the increasing elderly population and
subsequent increase in the demand for healthcare products and services. The medical device
market in Turkey was valued at approximately $1.8 billion in 2006. It grew at a CAGR of 4.8% from
2006 to 2011 and reached $2.2 billion in 2011. The market is predicted to reach to $3.3 billion by
2020. Turkey predominantly depends on imports for the medical devices. Turkey has a large
number of domestic producers also but these are involved with products which do not require high

2. technology.
Scope
- Overview of Turkey’s pharmaceutical and medical device markets, including size, segmentation
and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device
markets. Key players in the pharmaceutical market are Abdi Ibrahim, Novartis, Sanofi, Bilim and
Pfizer. Key players in the medical devices market are Siemens Healthcare, Roche, Essilor,
Fresenius and Baxter.
- Insightful review of the reimbursement and regulatory landscape, comprising details of the
healthcare reimbursement process, regulatory agencies and approval processes for new drugs
and medical devices
- Detailed analysis of Turkey’s political and economic environment, including economic indicators,
demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
This report comprehensively covers Turkey’s pharmaceutical and medical device markets and will
enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Turkey’s
healthcare market
- Drive revenues by understanding key trends, reimbursement and regulatory policies,
pharmaceutical and medical device market segments and companies likely to impact the
healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape
and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments
that present the most opportunities for consolidation, investment and strategic partnerships
- Identify, understand and capitalize on the opportunities and challenges in Turkey’s healthcare
market
Get your copy of this report @
http://www.reportsnreports.com/reports/209355-healthcare-regulatory-and-reimbursement-landscape-turkey.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 Report Guidance 11

3. 3 Overview of Pharmaceutical and Medical Devices Markets 12
3.1 Pharmaceutical Market 12
3.1.1 Market Overview 12
3.1.2 Supply Channels 14
3.1.3 Market Segments 15
3.1.4 Major Therapeutic Areas 20
3.1.5 Major Players 22
3.2 Medical Device Market 47
3.2.1 Market Overview 47
3.2.2 Overview of Top Five Segments 49
3.2.3 Major Players 60
3.3 Market Drivers and Barriers 83
3.3.1 Market Drivers 83
3.3.2 Market Barriers 83
4 Market Access 85
4.1 Reimbursement and Payer Landscape 85
4.1.1 Overview of Healthcare System 85
4.1.2 Reimbursement Process 88
4.1.3 Overview of Insurance Providers 89
4.1.4 Patient Share in Healthcare Spending 90
4.1.5 Pricing Trends in Healthcare Industry 91
4.1.6 Pricing Policies 91
4.2 Regulatory Landscape 92
4.2.1 Overview of Regulatory Agencies 92
4.2.2 Drug Approval Process 92
4.2.3 New Device Approval Process 94
4.2.4 Licensing Process for Manufacturing 95
4.2.5 Licensing Process for Pharmaceutical Imports 96
4.2.6 Intellectual Property Rights Landscape 96
4.2.7 Clinical Trial Regulations 96
4.2.8 Pharmaceutical Advertising Regulations 97
4.2.9 Pharmacy Regulations 98
4.2.10 Labeling and Packing Regulations 99
5 Country Analysis 100
5.1 Political Environment 100
5.1.1 Political Structure 100
5.1.2 Analysis of the Current Political Environment 101
5.1.3 Healthcare Policy Initiatives 102
5.2 Economic Landscape 103
5.3 Economic Indicators 104
5.3.1 Gross Domestic Product 104
5.3.2 Gross National Income 106

4. 5.3.3 Inflation 107
5.3.4 Currency Exchange Rate 110
5.3.5 Foreign Direct Investment 111
5.3.6 Foreign Exchange Reserves 112
5.3.7 Trade Balance 113
5.3.8 Government Structural Balance 115
5.3.9 Government Net Debt 116
5.3.10 Major Industries 117
5.4 Demographics 118
5.4.1 Population 118
5.4.2 Education and Literacy 133
5.4.3 Employment 136
5.4.4 Disease Burden 138
5.5 Healthcare Infrastructure 139
5.5.1 Healthcare Facilities 139
5.5.2 Healthcare Parameters 142
5.5.3 Environmental Health 144
5.5.4 Healthcare Personnel 148
5.6 Healthcare Expenditure 151
5.6.1 Overview 151
5.6.2 Health and Drug Expenditure 153
5.6.3 Health Expenditure Per Capita 155
5.6.4 Public and Private Sector Share 156
5.6.5 Spending on Pharmaceutical R&D 157
5.7 Trade Associations 158
5.7.1 Turkish Pharmacists’ Association 158
5.7.2 Pharmaceutical Manufacturer’s Association of Turkey 158
5.7.3 Turkish Confederation of Employer Associations 158
5.8 Trade Fairs 159
6 Opportunities and Challenges 160
6.1 Opportunities 160
6.2 Challenges 161
7 Appendix 162
7.1 Abbreviations 162
7.2 Bibliography 163
7.3 Methodology 167
7.3.1 Coverage 167
7.3.2 Secondary Research 167
7.3.3 Forecasting 168
7.3.4 Primary Research 168
7.3.5 Expert Panel Validation 168
7.4 Contact Us 168

5. 7.5 Disclaimer 169
1.1 List of Tables
Table 1: Pharmaceutical Market, Turkey, Revenue ($bn), 2005-2010 13
Table 2: Pharmaceutical Market, Turkey, Revenue Forecast ($bn), 2011-2020 14
Table 3: Supply Chain Margin, Turkey, Wholesaler and Pharmacist Profit (%), 2007 14
Table 4: Generic Market, Turkey, Revenue ($bn), 2006-2011 15
Table 5: Generic Market, Turkey, Revenue Forecast ($bn), 2012-2020 16
Table 6: Drugs Going Off-patent, Global, Revenue ($bn), 2011-2015 17
Table 7: OTC Pharmaceutical Market, Turkey, Revenue ($m), 2005-2010 18
Table 8: OTC Pharmaceutical Market, Turkey, Revenue Forecast ($m), 2011-2020 18
Table 9: OTC Pharmaceutical Market, Turkey, Segment Share (%), 2005 19
Table 10: Pharmaceutical Market, Turkey, Major Therapeutic Areas (%), 2007 20
Table 11: Major Products, Abdi Ibrahim, 2012 22
Table 12: Major Products, Novartis, Global, Revenue ($m), 2011 25
Table 13: Planned Filings, Novartis, 2012 to = 2016 26
Table 14: Major Products, Sanofi, Global, Revenue ($m), 2011 31
Table 15: Late-stage Pipeline, Sanofi, 2012 32
Table 16: Major Products, Pfizer, Global, Revenue ($m), 2011 40
Table 17: Late-stage Pipeline, Pfizer, 2012 41
Table 18: Medical Device Market, Turkey, Revenue ($bn), 2006-2011 47
Table 19: Medical Device Market, Turkey, Revenue Forecast ($bn), 2012-2020 48
Table 20: Medical Device Market, Turkey, Segments, Revenue ($m), 2011 49
Table 21: Ophthalmic Devices Market, Turkey, Revenue ($m), 2006-2011 50
Table 22: Sales Trends for Major Players*, Ophthalmic Devices, Turkey, 2010 51
Table 23: In Vitro Diagnostics Device Market, Turkey, Revenue ($m), 2006-2011 52
Table 24: Sales Trends for Major Players*, In Vitro Devices, Turkey, 2010 53
Table 25: Nephrology and Urology Devices Market, Turkey, Revenue ($m), 2006-2011 54
Table 26: Sales Trends for Major Players*, Nephrology and Urology Devices, Turkey, 2010 55
Table 27: Orthopedic Device Market, Turkey, Revenue ($m), 2006-2011 56
Table 28: Sales Trends for Major Players*, Orthopedic Devices, Turkey, 2010 57
Table 29: Diagnostic Imaging Devices Market, Turkey, Revenue ($m), 2006-2011 58
Table 30: Sales Trends for Major Players*, Diagnostic Imaging Devices, Turkey, 2010 59
Table 31: Major Medical Device Companies, Turkey, Revenue ($m), 2010 60
Table 32: Major Products, Siemens, Global, Revenue ($m), 2010 61
Table 33: Major Products, Roche, Global, Revenue ($m), 2010 64
Table 34: Late-stage Pipeline, F. Hoffmann-La Roche Ltd., 2012 65
Table 35: Major Products, Fresenius Medical, 2012 72
Table 36: Major Products, Baxter International, Global, Revenue ($m), 2010 79
Table 37: Healthcare Spending, Turkey, Patient Share (%), 2005-2010 90
Table 38: Healthcare Industry, Turkey, Price Change (%), 2006-2011 91
Table 39: Reimbursement Agency, Turkey, Pharmaceutical Discount (%), 2011 98

6. Table 40: GDP Per Capita ($’000), Turkey, 2006-2011 104
Table 41: GDP Per Capita, Forecast ($’000), Turkey, 2012-2020 105
Table 42: GDP, Turkey, Annual Growth (%), 2006-2011 105
Table 43: GDP, Turkey, Annual Growth Forecast (%), 2012-2020 106
Table 44: GNI Per Capita ($’000), Turkey, 2006-2011 106
Table 45: Average Consumer Price Index, Turkey, Annual Change (%), 2006-2011 107
Table 46: Average Consumer Price Index, Turkey, Annual Change Forecast, 2012-2020 108
Table 47: Average Consumer Price, Turkey, Annual Change (%), 2006-2011 109
Table 48: Average Consumer Price, Turkey, Annual Change Forecast (%), 2012-2020 109
Table 49: Currency Exchange Rate (TRY/$), Turkey, 2006-2011 110
Table 50: Foreign Direct Investment Inflow ($bn), Turkey, 2006-2011 111
Table 51: Foreign Exchange Reserves ($bn), Turkey, 2006-2011 112
Table 52: Exports of Goods and Services ($bn), Turkey, 2006-2011 113
Table 53: Imports of Goods and Services ($bn), Turkey, 2006-2011 114
Table 54: General Government Structural Balance ($bn), Turkey, 2005-2010 115
Table 55: General Government Structural Balance, Turkey, Forecast ($bn), 2011-2020 115
Table 56: General Government Net Debt ($bn), Turkey, 2005-2010 116
Table 57: General Government Net Debt, Turkey, Forecast ($bn), 2011-2020 116
Table 58: Major Industries, Turkey, Turnover ($bn), 2008 117
Table 59: Population (m), Turkey, 2006-2011 118
Table 60: Population, Turkey, Forecast (m), 2012-2020 119
Table 61: Urban and Rural Population, Turkey, Share (%), 2005-2010 120
Table 62: Urban and Rural Population, Turkey, Forecast Share (%), 2011-2020 121
Table 63: Age Groups, Turkey, Population Distribution (%), 2005-2010 122
Table 64: Age Groups, Turkey, Population Distribution Forecast (%), 2011-2020 123
Table 65: Births (Per 1,000 Population) Turkey, 2005-2010 124
Table 66: Mortality Rate (Per 1,000 Population), Turkey, 2005-2010 125
Table 67: Major Causes of Mortality (‘000), Turkey, 2008 126
Table 68: Children Table 69: Immunization Rate (%), Turkey, 2005-2010 128
Table 70: Major Causes of Male Mortality, Turkey (‘000), 2008 129
Table 71: Major Causes of Female Mortality (‘000), Turkey, 2008 130
Table 72: Gender Ratio (M/F), Turkey, 2005-2010 131
Table 73: Life Expectancy at Birth (Years), Turkey, 2005-2010 132
Table 74: Life Expectancy at Birth Forecast (Years), Turkey, 2011-2020 133
Table 75: Levels of Education, Turkey, Gross Enrolment (%), 2009 134
Table 76: Students Enrolled (m), Turkey, 2005-2010 135
Table 77: Unemployment Rate (%), Turkey, 2006-2011 136
Table 78: Employment, Turkey, Pharmaceutical Sector, Number of Employees (‘000), 1987-2007
137
Table 79: Major Diseases, Turkey, DALYs (Per 100,000 Population), 2004 138
Table 80: Public and Private Hospitals, Turkey, 2005-2010 139
Table 81: MRI Units in Hospitals (Per 100,000 Population), Turkey, 2005-2010 140

7. Table 82: CT Scan Units in Hospitals (Per 100,000 Population), Turkey, 2005-2010 141
Table 83: Beds (Per 1,000 Population), Turkey, 2005-2010 142
Table 84: Physicians (Per 1,000 Population), Turkey, 2005-2010 143
Table 85: Physicians (Per 1,000 Population), Forecast, Turkey, 2011-2020 144
Table 86: CO2 Emissions (Metric Tons), Turkey, 2005-2010 145
Table 87: Deaths Attributable to the Environment (Per 100,000 Population), Turkey, 2004 146
Table 88: PM10 (µg/m3), Turkey, 2005-2010 147
Table 89: Nurses (Per 1,000 Population), Turkey, 2005-2010 148
Table 90: Pharmacists (Per 100,000 Population), Turkey, 2005-2010 149
Table 91: Distribution of Pharmacists by Region, Turkey, 2003 149
Table 92: Dentists (Per 100,000 Population), Turkey, 2005-2010 150
Table 93: Healthcare Expenditure (% of GDP), Turkey, 2005-2010 151
Table 94: Healthcare Expenditure (% of GDP), Turkey, Forecast, 2011-2020 152
Table 95: Total Health and Drug Expenditure ($m), Turkey, 2000-2007 153
Table 96: Total Health and Drug Expenditure (%), Turkey, 2000-2007 154
Table 97: Healthcare Expenditure Per Capita ($), Turkey, 2001-2007 155
Table 98: Healthcare Expenditure, Turkey, Public-Private Share (%) 2005-2010 156
Table 99: Health R&D Expenditure ($m), Turkey, 2005-2010 157
Table 100: Major Healthcare Trade Fairs, Turkey, 2012 159
1.2 List of Figures
Figure 1: Pharmaceutical Market, Turkey, Imported and Local Drugs (%), 2007 13
Figure 2: Pharmaceutical Market, Turkey, Revenue ($bn), 2005-2010 13
Figure 3: Pharmaceutical Market, Turkey, Revenue Forecast ($bn), 2011-2020 14
Figure 4: Generic Market, Turkey, Revenue ($bn), 2006-2011 15
Figure 5: Generic Market, Turkey, Revenue Forecast ($bn), 2012-2020 16
Figure 6: OTC Pharmaceutical Market, Turkey, Revenue ($m), 2005-2010 18
Figure 7: OTC Pharmaceutical Market, Turkey, Revenue Forecast ($m), 2011-2020 18
Figure 8: OTC Pharmaceutical Market, Turkey, Segment Share (%), 2005 19
Figure 9: Pharmaceutical Market, Turkey, Major Therapeutic Areas (%), 2007 20
Figure 10: Medical Device Market, Turkey, Revenue ($bn), 2006-2011 47
Figure 11: Medical Device Market, Turkey, Revenue Forecast ($bn), 2012-2020 48
Figure 12: Medical Device Market, Turkey, Segments, Revenue ($m), 2011 49
Figure 13: Ophthalmic Devices Market, Turkey, Revenue ($m), 2006-2011 50
Figure 14: Sales Trends for Major Players*, Ophthalmic Devices, Turkey, 2006-2010 51
Figure 15: In Vitro Diagnostics Device Market, Turkey, Revenue ($m), 2006-2011 52
Figure 16: Sales Trends for Major Players*, In Vitro Devices, Turkey, 2006-2010 53
Figure 17: Nephrology and Urology Devices Market, Turkey, Revenue ($m), 2006-2011 54
Figure 18: Sales Trends for Major Players*, Nephrology and Urology Devices, Turkey, 2006-2010
55
Figure 19: Orthopedic Device Market, Turkey, Revenue ($m), 2006-2011 56
Figure 20: Sales Trends for Major Players*, Orthopedic Devices, Turkey, 2006-2010 57

8. Figure 21: Diagnostic Imaging Devices Market, Turkey, Revenue ($m), 2006-2011 58
Figure 22: Sales Trends for Major Players*, Diagnostic Imaging, Turkey, 2006-2010 59
Figure 23: Major Medical Device Companies, Turkey, Revenue ($m), 2010 60
Figure 24: Drivers and Barriers, Healthcare Market, Turkey, 2011 84
Figure 25: Organization Structure of SGK, Turkey, 2012 86
Figure 26: Reimbursement Process, Turkey, 2011 88
Figure 27: Healthcare Spending, Turkey, Patient Share (%), 2005-2010 90
Figure 28: Healthcare Industry, Turkey, Price Change (%), 2006-2011 91
Figure 29: Major Health Reforms, Turkey, 2003-2008 102
Figure 30: GDP Per Capita ($’000), Turkey, 2006-2011 104
Figure 31: GDP Per Capita, Forecast ($’000), Turkey, 2012-2020 105
Figure 32: GDP, Turkey, Annual Growth (%), 2006-2011 105
Figure 33: GDP, Turkey, Annual Growth Forecast (%), 2012-2020 106
Figure 34: GNI Per Capita ($’000), Turkey, 2006-2011 106
Figure 35: Average Consumer Price Index, Turkey, Annual Change (%), 2006-2011 107
Figure 36: Average Consumer Price Index, Turkey, Annual Change Forecast (%), 2012-2020 108
Figure 37: Average Consumer Price, Turkey, Annual Change (%), 2006-2011 109
Figure 38: Average Consumer Price, Turkey, Annual Change Forecast (%), 2012-2020 109
Figure 39: Currency Exchange Rate (TRY/$), Turkey, 2006-2011 110
Figure 40: Foreign Direct Investment Inflow ($bn), Turkey, 2006-2011 111
Figure 41: Foreign Exchange Reserves ($bn), Turkey, 2006-2011 112
Figure 42: Exports of Goods and Services ($bn), Turkey, 2006-2011 113
Figure 43: Imports of Goods and Services ($bn), Turkey, 2006-2011 114
Figure 44: General Government Structural Balance ($bn), Turkey, 2005-2010 115
Figure 45: General Government Structural Balance, Turkey, Forecast ($bn), 2011-2020 115
Figure 46: General Government Net Debt ($bn), Turkey, 2005-2010 116
Figure 47: General Government Net Debt, Turkey, Forecast ($bn), 2011-2020 116
Figure 48: Major Industries, Turkey, Turnover ($bn), 2008 117
Figure 49: Population (m), Turkey, 2006-2011 118
Figure 50: Population (m), Turkey, Forecast, 2012-2020 119
Figure 51: Urban and Rural Population, Turkey, Share (%), 2005-2010 120
Figure 52: Urban and Rural Population, Turkey, Forecast Share (%), 2011-2020 121
Figure 53: Age Groups, Turkey, Population Distribution (%), 2005-2010 122
Figure 54: Age Groups, Turkey, Population Distribution Forecast (%), 2011-2020 123
Figure 55: Births (Per 1,000 Population), Turkey, 2005-2010 124
Figure 56: Mortality Rate (Per 1,000 Population), Turkey, 2005-2010 125
Figure 57: Major Causes of Mortality (‘000), Turkey, 2008 126
Figure 58: Children Figure 59: Immunization Rate, Turkey (%), 2005-2010 128
Figure 60: Major Causes of Male Mortality, Turkey (‘000), 2008 129
Figure 61: Major Causes of Female Mortality (‘000), Turkey, 2008 130
Figure 62: Gender Ratio (M/F), Turkey, 2005-2010 131
Figure 63: Life Expectancy at Birth (Years), Turkey, 2005-2010 132

9. Figure 64: Life Expectancy at Birth Forecast (Years), Turkey, 2011-2020 133
Figure 65: Levels of Education, Turkey, Gross Enrolment (%), 2009 134
Figure 66: Students Enrolled (m), Turkey, 2005-2010 135
Figure 67: Unemployment Rate (%), Turkey, 2006-2011 136
Figure 68: Employment, Turkey, Pharmaceutical Sector, Number of Employees (‘000), 1987-2007
137
Figure 69: Major Diseases, Turkey, DALYs (Per 100,000 Population), 2004 138
Figure 70: Public and Private Hospitals, Turkey, 2005-2010 139
Figure 71: MRI Units in Hospitals (Per 100,000 Population), Turkey, 2005-2010 140
Figure 72: CT Scan Units in Hospitals (Per 100,000 Population), Turkey, 2005-2010 141
Figure 73: Beds (Per 1,000 Population), Turkey, 2005-2010 142
Figure 74: Physicians (Per 1,000 Population), Turkey, 2005-2010 143
Figure 75: Physicians (Per 1,000 Population), Forecast, Turkey, 2011-2020 144
Figure 76: CO2 Emissions (Metric Tons), Turkey, 2005-2010 145
Figure 77: Deaths Attributable to the Environment (Per 100,000 Population), Turkey, 2004 146
Figure 78: PM10 (µg/m3), Turkey, 2005-2010 147
Figure 79: Nurses (Per 1,000 Population), Turkey, 2005-2010 148
Figure 80: Pharmacists (Per 100,000 Population), Turkey, 2005-2010 149
Figure 81: Dentists (Per 100,000 Population), Turkey, 2005-2010 150
Figure 82: Healthcare Expenditure (% of GDP), Turkey, 2005-2010 151
Figure 83: Healthcare Expenditure (% of GDP), Turkey, Forecast, 2011-2020 152
Figure 84: Drug Expenditure Share ($m), Turkey, 2000-2007 153
Figure 85: Drug Expenditure, Turkey, Share (%), 2000-2007 154
Figure 86: Healthcare Expenditure Per Capita ($), Turkey, 2001-2007 155
Figure 87: Healthcare Expenditure, Turkey, Public-Private Share (%) 2005-2010 156
Figure 88: Health R&D Expenditure ($m), Turkey, 2005-2010 157
Figure 89: Opportunities and Challenges, Healthcare Market, Turkey, 2011 161
Contact: sales@reportsandreports.com for more information.